Bio-Connect
Product image
Product image
Product image

InVivoMAb anti-human CD4

Research Use Only
BE0288
Bio X Cell
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-human CD4
  • Delivery Days Customer
    7
  • Applications
    Flow Cytometry, ImmunoFluorescence, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    RPA-T4
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Mouse
  • Isotype
    IgG1
  • Scientific Description
    The RPA-T4 monoclonal antibody reacts with the human CD4. The CD4 antigen is a 55 kDa cell surface type I membrane glycoprotein belonging to the immunoglobulin superfamily. CD4 acts as a co-receptor which in cooperation with the T cell receptor (TCR) interacts with class II MHC molecules displayed by antigen presenting cells (APC). CD4 is expressed by most thymocytes and helper T cells, a subset of NK-T cells and weakly by dendritic cells and macrophages. CD4 plays an important role in the development of T cells and is required for mature T cells to function optimally. The RPA-T4 antibody is reported to bind to the D1 domain of CD4 and does not block the binding of the OKT-4 antibody. Additionally, RPA-T4 has been shown to block the binding of HIV gp120 protein to CD4 and inhibit CD4 T cell activation in vitro.
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry. Moolla N et al., 2016 Sep, Biochim Biophys Acta
    Read more
  • CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs. Mayer CT et al., 2013 Dec, J Autoimmun
    Read more
  • Loss of asparagine-linked glycosylation sites in variable region 5 of human immunodeficiency virus type 1 envelope is associated with resistance to CD4 antibody ibalizumab. Toma J et al., 2011 Apr, J Virol
    Read more
  • Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Mack CL et al., 2004 Jul, Pediatr Res
    Read more
  • DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Geijtenbeek TB et al., 2000 Mar 3, Cell
    Read more
  • CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir. Moir S et al., 1999 Oct, J Virol
    Read more

Related products

Product image
Product group Antibodies
References
Bio X Cell
  • SizePrice
Product image
Product group Chemicals
Bio X Cell
  • SizePrice